USPTO serial 79266031
FAST-TRACK DIAGNOSTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 30, 2021
- Examiner
- SAITO, KIM
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with FAST-TRACK DIAGNOSTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Fast-Track Diagnostics Luxembourg S.a.r.l.
LU
Other trademarks owned by Fast-Track Diagnostics Luxembourg S.a.r.l.
Fast-Track Diagnostics Luxembourg S.a.r.l.
LU
Other trademarks owned by Fast-Track Diagnostics Luxembourg S.a.r.l.
Fast-Track Diagnostics Luxembourg S.a.r.l.
LU
Other trademarks owned by Fast-Track Diagnostics Luxembourg S.a.r.l.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marie Anne Mastrovito
Marie Anne Mastrovito Womble Bond Dickinson (US) LLP950 3rd Avenue, Suite 2400New York, NY 10022UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry; chemicals for use in science; chemical preparations for analytical and diagnostic purposes in laboratory use other than for medical or veterinary purposes, chemical preparations for analytical and diagnostic purposes, namely, reagent kits comprising oligonucleotides and polynucleotides, polymerase and buffer for use in the biotechnology fields; proteins for immunoassay for medical research purposes in the field of detection of cancers, bacteria, fungi, autoimmune disease, infection, gastrointestinal disorders and diseases, viruses, sexually transmitted diseases, influenza, liver diseases, blood diseases and disorders, cardiovascular disease, liver dysfunction, kidney dysfunction, inflammatory disease and for toxicological studies for scientific use; chemical products, namely, proteins for immunoassay for scientific and medical research; chemicals, namely, proteins for analytical purposes, diagnostic purposes and medical research use, other than for medical and veterinary use; laboratory testing chemicals and reagents for research purposes containing proteins and immunoassay reagents; chemicals, namely, proteins for analytical purposes, diagnostic purposes for medical research use other than for medical and veterinary use; laboratory chemicals, namely, antibody reagent used for the detection of antigens in cell and tissue and body fluid sample analysis for in vitro diagnostic use; laboratory chemicals for analytical purposes other than for medical and veterinary use; biological reagents for use in molecular biology, other than for medical and veterinary use; chemical test reagents for scientific and research use | ACTIVE | — |
| 005 | Diagnostic preparations for medical or veterinary purposes; pharmaceutical preparations for treatment of cancers, bacterial infections, fungal infections, viral infections, autoimmune disease, gastrointestinal disorders and diseases, viruses, sexually transmitted diseases, influenza, liver diseases, blood diseases and disorders, cardiovascular disease, liver dysfunction, kidney dysfunction, and inflammatory diseases; chemicals for medical purposes, namely, for use in the treatment and prevention of treatment of cancers, bacterial infections, fungal infections, viral infections, autoimmune disease, gastrointestinal disorders and diseases, viruses, sexually transmitted diseases, influenza, liver diseases, blood diseases and disorders, cardiovascular disease, liver dysfunction, kidney dysfunction, and inflammatory diseases; diagnostic proteins for medical laboratory analysis, namely, protein and nucleic acid arrays for diagnostic purposes used in medical laboratories; diagnostic reagents for medical and veterinary use; reagents for medical and veterinary use; chemical reagents for medical or veterinary purposes; chemical reagents for use in medicine | ACTIVE | — |
| 010 | Testing, analysis and diagnostic apparatus and instruments for medical diagnostic purposes, namely, PCR thermocycler, immunoassay analyzers, clinical chemistry analyzers, medical diagnostic instruments for analysis of body fluids, medical instruments for analyzing and identifying bacteria, flow cytometers for medical diagnostic uses | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Fast-Track Diagnostics Luxembourg S.a.r.l.
- Other trademarks owned by Fast-Track Diagnostics Luxembourg S.a.r.l.
- Other trademarks owned by Fast-Track Diagnostics Luxembourg S.a.r.l.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named FAST-TRACK DIAGNOSTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 30, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 25, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jul 22, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 22, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 22, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 22, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 24, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 4, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 1, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jul 1, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jun 30, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 30, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 13, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 27, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 27, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 12, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 12, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 9, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 23, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 23, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 23, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 7, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 7, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 7, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 7, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 7, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 20, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 19, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 19, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 15, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 15, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 15, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 19, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 19, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 19, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 19, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 13, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 13, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 13, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 13, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 14, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 14, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 24, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 23, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 12, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 10, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 4, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 22, 2019 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |